Home Healthcare Market to Cross US$ 8,78,383.5 Million, Rising at a CAGR of 9.8% by 2034: Fact.MR Report

The global home healthcare industry is expected to be worth US$3,45,256.6 million in 2024. Through 2034, the market is expected to expand rapidly at a 9.8% CAGR. By 2034, the market is expected to grow to US$ 8,78,383.5 million.

There is an increasing need for in-home healthcare services as the number of senior people rises. Additionally, there is a growing need for the specialized care provided by home healthcare professionals due to the rising prevalence of certain maladies like dementia, Alzheimer's disease, and orthopedic illnesses. Given that many patients would rather receive care at home than in a hospital or nursing home, this is particularly important.

𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9397

The home healthcare industry is expected to grow as a result of technological advancements like telemedicine and remote monitoring equipment, which will enable more effective and affordable care. In general, it is anticipated that the home healthcare market would grow quickly during the next ten years.

A major obstacle that the industry must overcome is the dearth of qualified providers of home healthcare services. The market's growth is being hindered by the fact that becoming a home healthcare provider requires specialized training and skills that are in high demand. The lack of qualified specialists as a result prevents the home healthcare industry from growing.

"Governments and healthcare organizations around the world are very concerned about the rising cost of healthcare. Many people are using options like home healthcare, which is less expensive than a hospital stay, to address this problem, according to a Fact.MR analyst.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

From 2024 to 2034, the home healthcare market is expected to grow at a compound annual growth rate (CAGR) of 9.8%.

From 2024 to2034, the home healthcare market in North America is anticipated to expand at a CAGR of 9.3%.

Throughout the projected period, the US market is anticipated to grow at a CAGR of 9.1%.

Through 2034, the Chinese home healthcare market is anticipated to grow at a CAGR of 9.9%.

With an anticipated share of 38.0% in 2024, the nursing category dominates the market in terms of service type.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭

Abbott,
3M Healthcare,
Baxter International Inc.,
Medtronic PLC,
Cardinal Health Inc.,
Air Liquide,
Amedisys, Inc.,
NxStage Medical, Inc.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

To capitalize on the substantial market growth potential of emerging nations and new markets, industry companies are concentrating on expanding their operations in these areas. In response to these issues, suppliers are aggressively developing innovative goods and services in an effort to capitalize on opportunities for market expansion.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9397

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭

Abbott just released NeuroSphere myPath in 2021, a new piece of digital health software meant to help physicians monitor and treat patients with chronic pain. With this improved version, physicians can monitor patients' development and administer more specialized care. Service providers are collaborating to raise the standard of care.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.